Solventum Corp. (SOLV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Solventum Corp. (SOLV) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($76.00 Million) by net assets ($4.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Solventum Corp. balance sheet quality to measure how much of total assets are equity-financed.
Solventum Corp. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Solventum Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Solventum Corp. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Solventum Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Solventum Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZTO Express (Cayman) Inc
NYSE:ZTO
|
0.178x |
|
Zhejiang Nhu Co Ltd
SHE:002001
|
0.069x |
|
China Galaxy Securities Co Ltd Class A
SHG:601881
|
0.098x |
|
Coloplast A/S
CO:COLO-B
|
0.162x |
|
Pro Medicus Ltd
AU:PME
|
0.178x |
|
Mr. Cooper Group Inc
NASDAQ:COOP
|
0.058x |
|
Toll Brothers Inc
NYSE:TOL
|
0.016x |
|
Guangxi Guiguan Electric Power Co Ltd
SHG:600236
|
0.114x |
Annual Cash Flow Conversion Efficiency for Solventum Corp. (2021–2024)
The table below shows the annual cash flow conversion efficiency of Solventum Corp. from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see SOLV company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.96 Billion | $1.19 Billion | 0.400x | +143.96% |
| 2023-12-31 | $11.67 Billion | $1.92 Billion | 0.164x | +14.80% |
| 2022-12-31 | $11.74 Billion | $1.68 Billion | 0.143x | -21.69% |
| 2021-12-31 | $12.06 Billion | $2.20 Billion | 0.183x | -- |
About Solventum Corp.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advance… Read more